Pfizer, Gilead, GSK to lead $150 bn infectious diseases mkt by 2029: Report
Pharma giants Pfizer, Gilead Sciences, and GSK are expected to collectively generate 62 per cent of total infectious disease drug ...
Tag: GSK to lead $150 bn infectious diseases mkt by 2029: Report
EDITOR'S PICK
